Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: The Rotterdam Study

Osteoporosis International

Volumn 25, Issue 4, 2014, Pages 1247-1254

  Oei, L ^a,b   Campos Obando, N ^a,b   Dehghan, A ^a,b   Oei, E H G ^a   Stolk, L ^a,b   Van Meurs, J B J ^a,b   Hofman, A ^a,b   Uitterlinden, A G ^a,b   Franco, O H ^a,b   Zillikens, M C ^a,b   Rivadeneira, F ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Genomics Initiative   (Netherlands)

Author keywords

C reactive protein; Diseases and disorders of related to bone; Epidemiology; Fracture risk assessment; General population studies; Osteoimmunology

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

AGE; AGED; ARTICLE; BODY MASS; BONE BOWING; BONE DENSITY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORRELATIONAL STUDY; DNA POLYMORPHISM; FEMALE; FEMUR NECK; FOLLOW UP; GENDER; GENETIC RISK; GENOTYPE; HAPLOTYPE MAP; HIP BONE GEOMETRY; HIP FRACTURE; HUMAN; INFLAMMATORY DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MUSCULOSKELETAL SYSTEM PARAMETERS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE FRACTURE; WRIST FRACTURE; BLOOD; GENETICS; INCIDENCE; LUMBAR VERTEBRA; MIDDLE AGED; NETHERLANDS; OSTEOPOROTIC FRACTURES; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; C-REACTIVE PROTEIN; FEMALE; FEMUR NECK; GENOTYPE; HUMANS; INCIDENCE; LUMBAR VERTEBRAE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NETHERLANDS; OSTEOPOROTIC FRACTURES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84897022297     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2578-0     Document Type: Article

References (48)

1. Krieckaert CL, Lems WF (2012) Biologicals and bone loss. Ther Adv Musculoskelet Dis 4:245-247
2. Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JD, Schneider HG (2006) High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 296:1353-1355 (Pubitemid 44427419)
3. Hardy R, Cooper MS (2009) Bone loss in inflammatory disorders. J Endocrinol 201:309-320
4. Watson J, Round A, Hamilton W (2012) Raised inflammatory markers. BMJ 344:e454
5. de Pablo P, Cooper MS, Buckley CD (2012) Association between bone mineral density and C-reactive protein in a large population-based sample. Arthritis Rheum 64:2624-2631
6. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G (2008) Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93:1952-1958 (Pubitemid 351656543)
7. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS (2005) Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16:1263-1271 (Pubitemid 41396955)
8. Rolland T, Boutroy S, Vilayphiou N, Blaizot S, Chapurlat R, Szulc P (2012) Poor trabecular microarchitecture at the distal radius in older men with increased concentration of high-sensitivity C-reactive protein - the STRAMBO study. Calcif Tissue Int 90:496-506
9. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K (2005) Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc 97:329-333 (Pubitemid 40315936)
10. Ebrahim S, Davey Smith G (2008) Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 123:15-33
11. Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309-330 (Pubitemid 47215256)
12. Gray R, Wheatley K (1991) How to avoid bias when comparing bone-marrow transplantation with chemotherapy. Bone Marrow Transplant 7:9-12
13. Dupuis J, Larson MG, Vasan RS, Massaro JM, Wilson PW, Lipinska I, Corey D, Vita JA, Keaney JF Jr, Benjamin EJ (2005) Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 182:307-314 (Pubitemid 41267199)
14. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP (2001) Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154:681-689 (Pubitemid 32232166)
15. Retterstol L, Eikvar L, Berg K (2003) A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169:279-282 (Pubitemid 37297474)
16. Dehghan A, Dupuis J, Barbalic M et al (2011) Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123:731-738
17. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359:1897-1908
18. Hofman A, van Duijn CM, Franco OH et al (2011) The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 26:657-686
19. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, Stijnen T, Hofman A, Schram MT, Witteman JC (2007) Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56:872-878 (Pubitemid 46348467)
20. McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, Kanis JA (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3:138-147 (Pubitemid 23125375)
21. Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA (2002) The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 17:1051-1056 (Pubitemid 34535143)
22. Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A, Pols HA (1998) Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol 147:871-879
23. Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW (2000) Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15:2297-2304
24. Rivadeneira F, Zillikens MC, De Laet CE, Hofman A, Uitterlinden AG, Beck TJ, Pols HA (2007) Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study. J Bone Miner Res 22:1781-1790 (Pubitemid 351235145)
25. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346-1353 (Pubitemid 14231480)
26. Odding E, Valkenburg HA, Algra D, Vandenouweland FA, Grobbee DE, Hofman A (1995) Association of locomotor complaints and disability in the Rotterdam study. Ann Rheum Dis 54:721-725
27. International HapMap Consortium (2003) The International HapMap Project. Nature 426:789-796
28. Altshuler DM, Gibbs RA, Peltonen L et al (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467:52-58
29. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585-590 (Pubitemid 38500312)
30. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397 (Pubitemid 38419992)
31. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334 (Pubitemid 32656163)
32. Brunner EJ, Kivimaki M, Witte DR et al (2008) Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5:e155
33. Dirven L, van den Broek M, van Groenendael JH, de Beus WM, Kerstens PJ, Huizinga TW, Allaart CF, Lems WF (2012) Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord 13:125
34. Orstavik RE, Haugeberg G, Mowinckel P, Hoiseth A, Uhlig T, Falch JA, Halse JI, McCloskey E, Kvien TK (2004) Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 164:420-425 (Pubitemid 38240706)
35. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterology 125:1591-1597 (Pubitemid 37500422)
36. Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) 39:85-89 (Pubitemid 30095412)
37. van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, Dijkmans BA, Heymans MW, Lems WF (2012) High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int 23:1683-1690
38. van der Weijden MA, Claushuis TA, Nazari T, Lems WF, Dijkmans BA, van der Horst-Bruinsma IE (2012) High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol 31:1529-1535
39. Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R (2011) Bone geometry profiles in women with and without SLE. J Bone Miner Res 26:2719-2726
40. Oei L, Zillikens MC, Dehghan A et al (2013) High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care 36:1619-1628
41. Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, Yu Q, Zillikens MC, Gao X, Rivadeneira F (2012) Association between bonemineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27:319-332
42. Ishii S, Cauley JA, Greendale GA, Crandall CJ, Danielson ME, Ouchi Y, Karlamangla AS (2013) C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res 28:1688-1698
43. Quinn JM, Gillespie MT (2005) Modulation of osteoclast formation. Biochem Biophys Res Commun 328:739-745 (Pubitemid 40208311)
44. Tanabe N, Ito-Kato E, Suzuki N, Nakayama A, Ogiso B, Maeno M, Ito K (2004) IL-1alpha affects mineralized nodule formation by rat osteoblasts. Life Sci 75:2317-2327 (Pubitemid 39180040)
45. den Uyl D, Bultink IE, Lems WF (2011) Glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 29:S93-98
46. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328 (Pubitemid 47389469)
47. Kaji H, Yamauchi M, Chihara K, Sugimoto T (2008) Glucocorticoid excess affects cortical bone geometry in premenopausal, but not postmenopausal, women. Calcif Tissue Int 82:182-190
48. Pierce BL, Ahsan H, Vanderweele TJ (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40:740-752